Kayleen Brown

1 week ago | devicetalks.com | Kayleen Brown

In this episode of Structural Heart Talks, Joe Nuzzolese, corporate VP of global supply chain and quality at Edwards Lifesciences, shares how the company has built a resilient and responsive supply chain capable of withstanding significant disruptions—pandemic included—without missing a single patient case. Nuzzolese explains how Edwards takes a “plan, make, source, deliver” approach, and why MedTech supply chains differ from consumer goods with a stronger emphasis on quality and availability.

2 weeks ago | devicetalks.com | Kayleen Brown

In this episode of DeviceTalks Weekly Podcast, Host Tom Salemi tracks the career of CorVista Health CEO Adrian Lam, an engineer turned financer turned VC turned CEO. CorVista is bringing AI to bear on cardiac diagnostics, helping hospitals and doctors identify who need the most care. Before that talk we’ll hear from Scott Frasier of Fraser Healthcare about what ambulatory surgery centers mean for the future of MedTech.

3 weeks ago | devicetalks.com | Kayleen Brown

In this episode of the DeviceTalks Weekly podcast, Dr. Nadine Hashash-Haram discusses her journey as a surgeon and the founder of Proxime, a digital health platform that enhances surgical procedures through technology. She shares insights on the evolution of Proxime, its impact on healthcare systems, and the importance of collaboration with medical device companies.

4 weeks ago | devicetalks.com | Kayleen Brown

In this week’s episode of the DeviceTalks Weekly Podcast, Andrew Cleeland, CEO of the Fogarty Institute, shares his MedTech story, starting with a serendipitous move into the industry. Cleeland, of course, went on to lead two successful startups from The Foundry – Ardian and Twelve, that both went on to be acquired by Medtronic. Cleeland now leads one of the industry’s most successful incubator programs, the Fogarty Institute.

1 month ago | devicetalks.com | Kayleen Brown

In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi interviews Alan Lotvin, MD, the CEO and co-founder of Sequel Med Tech, a small company promoting another BIG idea from prolific inventor Dean Kamen. Lotvin, who was formerly a senior executive at CVS/Caremark and PBMs, explains how Twiist, the automated insulin delivery system, could be a game-changer for people with diabetes. Before the interview, we’ll hear from Ivan Tornos, the CEO and president of Zimmer Biomet.